Biomaterial Database

Ganciclovir treatment of congenital cytomegalovirus infection: a report of two cases. 1993

S P Attard-Montalto, and M C English, and L Stimmler, and G J Snodgrass

Department of Paediatrics, St. Bartholomew's Hospital, London, England.

Ganciclovir has been shown to be effective against cytomegalovirus (CMV) in vitro, but its role in the treatment of congenital cytomegalovirus infection is unknown. We describe its use in the management of two cases of congenital CMV infections. The drug was well tolerated and virus shedding in the urine was eliminated, though hepatosplenomegaly and neurodevelopmental delay persisted in both cases.

UI	MeSH Term	Description	Entries
D007223	Infant	A child between 1 and 23 months of age.	Infants
D007231	Infant, Newborn	An infant during the first 28 days after birth.	Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007262	Infusions, Intravenous	The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it.	Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D008297	Male		Males
D012008	Recurrence	The return of a sign, symptom, or disease after a remission.	Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D003586	Cytomegalovirus Infections	Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults.	CMV Inclusion,CMV Inclusions,Congenital CMV Infection,Congenital Cytomegalovirus Infection,Cytomegalic Inclusion Disease,Cytomegalovirus Colitis,Cytomegalovirus Inclusion,Cytomegalovirus Inclusion Disease,Cytomegalovirus Inclusions,Inclusion Disease,Perinatal CMV Infection,Perinatal Cytomegalovirus Infection,Renal Tubular Cytomegalovirus Inclusion,Renal Tubular Cytomegalovirus Inclusions,Salivary Gland Virus Disease,Severe Cytomegalovirus Infection,Severe Cytomegalovirus Infections,Infections, Cytomegalovirus,CMV Infection, Congenital,CMV Infection, Perinatal,Colitis, Cytomegalovirus,Congenital CMV Infections,Congenital Cytomegalovirus Infections,Cytomegalic Inclusion Diseases,Cytomegalovirus Colitides,Cytomegalovirus Inclusion Diseases,Cytomegalovirus Infection,Cytomegalovirus Infection, Congenital,Cytomegalovirus Infection, Perinatal,Cytomegalovirus Infection, Severe,Cytomegalovirus Infections, Severe,Disease, Cytomegalic Inclusion,Disease, Cytomegalovirus Inclusion,Diseases, Cytomegalovirus Inclusion,Inclusion Disease, Cytomegalic,Inclusion Disease, Cytomegalovirus,Inclusion Diseases,Inclusion Diseases, Cytomegalovirus,Inclusion, CMV,Inclusion, Cytomegalovirus,Infection, Congenital CMV,Infection, Congenital Cytomegalovirus,Infection, Cytomegalovirus,Infection, Perinatal CMV,Infection, Perinatal Cytomegalovirus,Infection, Severe Cytomegalovirus,Perinatal CMV Infections,Perinatal Cytomegalovirus Infections
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015774	Ganciclovir	An ACYCLOVIR analog that is a potent inhibitor of the Herpesvirus family including cytomegalovirus. Ganciclovir is used to treat complications from AIDS-associated cytomegalovirus infections.	BIOLF-62,BW-759,Cytovene,Ganciclovir Sodium,Ganciclovir, Monosodium Salt,Gancyclovir,RS-21592

Related Publications

S P Attard-Montalto, and M C English, and L Stimmler, and G J Snodgrass

[Ganciclovir treatment of congenital cytomegalovirus infection].

April 2006, Orvosi hetilap,

S P Attard-Montalto, and M C English, and L Stimmler, and G J Snodgrass

Ganciclovir treatment of symptomatic congenital cytomegalovirus infection.

September 2002, The Journal of antimicrobial chemotherapy,

S P Attard-Montalto, and M C English, and L Stimmler, and G J Snodgrass

Ganciclovir treatment of children with congenital cytomegalovirus infection.

January 2004, The Pediatric infectious disease journal,

S P Attard-Montalto, and M C English, and L Stimmler, and G J Snodgrass

Treatment of children with congenital cytomegalovirus infection with ganciclovir.

June 2003, The Pediatric infectious disease journal,

S P Attard-Montalto, and M C English, and L Stimmler, and G J Snodgrass

[Different dosages Ganciclovir treatment of symptomatic congenital cytomegalovirus infection in neonatal].

February 2012, Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology,

S P Attard-Montalto, and M C English, and L Stimmler, and G J Snodgrass

Ganciclovir therapy for symptomatic congenital cytomegalovirus infection in infants: a two-regimen experience.

February 1994, The Journal of pediatrics,

S P Attard-Montalto, and M C English, and L Stimmler, and G J Snodgrass

[Treatment with ganciclovir of congenital cytomegalovirus infections].

June 1996, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,

S P Attard-Montalto, and M C English, and L Stimmler, and G J Snodgrass

Ganciclovir therapy for neonates with congenital cytomegalovirus infection.

June 2007, European journal of pediatrics,

S P Attard-Montalto, and M C English, and L Stimmler, and G J Snodgrass

[Congenital cytomegalovirus infection. The role of ganciclovir in newborns].

February 2014, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,